Melissa K. Thomas

Effects of subcutaneous tirzepatide versus placebo or semaglutide on pancreatic islet function and insulin sensitivity in adults with type 2 diabetes: a multicentre, randomised, double-blind, parallel-arm, phase 1 clinical trial.

T. Heise, J. DeVries, A. Mari, 2022, The lancet. Diabetes & endocrinology.

Discovery of LY3325656: A GPR142 agonist suitable for clinical testing in human.

Hua V. Lin, Melissa K Thomas, Jia Liu, 2019, Bioorganic & medicinal chemistry letters.

LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept.

Matthew M. Abernathy, R. Gimeno, F. Willard, 2022, Cell metabolism.

Muscle sphingolipids during rest and exercise: a C18:0 signature for insulin resistance in humans

B. Bergman, J. Brozinick, L. Perreault, 2016, Diabetologia.